Skip to main content
    Physician-selected

    Physician-selected · Investigational

    Retatrutide,
    when your physician selects it.

    Retatrutide is part of ELEVATED GLP-1, alongside semaglutide and tirzepatide. Your physician can select it after your $79 Wellness Assessment. It is investigational and not FDA-approved, and it is never sold as a self-serve checkout.

    See every ELEVATED GLP-1 option

    First step

    $79

    Wellness Assessment in Evans.

    If selected

    $299–$529/mo

    ELEVATED GLP-1 · Retatrutide, price follows weekly dose. Physician decision only — not a self-serve checkout.

    Also in ELEVATED GLP-1

    Sema / Tirz

    Semaglutide and tirzepatide. Your physician chooses among the three after your assessment.

    What it is

    Physician-selected, and never a click-to-buy.

    Retatrutide is part of ELEVATED GLP-1 here, with the same in-person Evans care as every ELEVATED program. Your physician decides whether it fits after your Wellness Assessment.

    • Investigational triple-receptor agonist (GIP / GLP-1 / glucagon)
    • Offered only after the $79 Wellness Assessment
    • Requires GLP-1 informed consent with Section 11A
    • If prescribed, obtained only through the clinic's designated supplier, never gray-market vendors
    • Not a promise of any specific result
    • Not available as online self-checkout
    • Not a wait list or early-access list
    • Not a claim that compounding is FDA-authorized

    Investigational medication

    Retatrutide is investigational. It is not FDA-approved for any use. The FDA has stated that retatrutide does not qualify for pharmacy compounding exemptions under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act, and has warned firms marketing compounded or “research” retatrutide. Offering it here is a physician clinical decision after your Wellness Assessment. That decision does not change federal law. If prescribed, it is obtained only through the clinic's designated supplier, never gray-market vendors. Individual results vary.

    How it works

    Same front door as every consult-gated program.

    01

    Wellness Assessment ($79)

    In-person visit in Evans. History, medications, and whether any GLP-1 path — including this option — is appropriate.

    02

    Physician review

    Your physician decides. Retatrutide is never self-selected online and is not offered as a wait-list or à la carte click-to-buy.

    03

    Consent

    If selected, you sign the GLP-1 consent including Section 11A — investigational status, not FDA-approved, and the FDA compounding position.

    04

    Ongoing program care

    $299–$529/mo (price follows weekly dose) includes medication when prescribed, monthly check-ins, quarterly labs, and messaging. Dose changes stay with your clinician.

    FAQ

    Questions, answered.

    Start with your assessment.

    Retatrutide is not available for self-selection or online checkout. Your physician decides after the Wellness Assessment.

    Or call (706) 760-3470